Zhiming Xu Selected Research

Reactive Oxygen Species (Oxygen Radicals)

10/2023	Attenuates reactive oxygen species: induced pyroptosis via activation of the Nrf2/HO-1 signal pathway in models of trigeminal neuralgia.
1/2020	A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
1/2017	Sesamin protects SH-SY5Y cells against mechanical stretch injury and promoting cell survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiming Xu Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 01/2014
4	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 01/2017
3	Inflammation (Inflammations) 04/2024 - 08/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2018
2	Pituitary Neoplasms (Pituitary Adenoma) 12/2017 - 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023
1	Necrosis 12/2023
1	Trigeminal Neuralgia (Tic Douloureux) 10/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Osteoarthritis 01/2023
1	Ischemic Stroke 01/2023
1	Stroke (Strokes) 01/2023
1	Infections 12/2022
1	Carcinogenesis 08/2022
1	Pain (Aches) 02/2022
1	Neuroinflammatory Diseases 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	COVID-19 10/2021
1	Femoral Fractures (Femoral Fracture) 05/2021
1	Bone Fractures (Bone Fracture) 05/2021
1	Infertility (Sterility) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Kidney Diseases (Kidney Disease) 03/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2020
1	Reperfusion Injury 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Ischemia 01/2020
1	Embolic Stroke 12/2019
1	Choristoma (Ectopic Tissue) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 12/2018
1	Cerebral Infarction 12/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Neuroblastoma 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Vascular System Injuries 01/2014
1	Melanoma (Melanoma, Malignant) 05/2012

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 04/2024 - 08/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2014
2	CytokinesIBA 04/2024 - 12/2018
2	AntioxidantsIBA 12/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 12/2014
2	CateninsIBA 01/2020 - 12/2018
2	Cadherins (E-Cadherin)IBA 01/2019 - 12/2018
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 04/2024
1	NF-kappa B (NF-kB)IBA 12/2023
1	catalpolIBA 12/2023
1	IridoidsIBA 12/2023
1	Caspase 9IBA 12/2023
1	InterleukinsIBA 12/2023
1	Caspase 3 (Caspase-3)IBA 12/2023
1	beta CateninIBA 01/2023
1	AlbuminsIBA 12/2022
1	Blood Glucose (Blood Sugar)IBA 12/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2022
1	ACT001IBA 01/2022
1	Factor VII (Proconvertin)IBA 01/2022
1	cyasteroneIBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 03/2020
1	Neuroprotective AgentsIBA 01/2020
1	triptolideIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	artenimol (dihydroartemisinin)IBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Buthionine SulfoximineIBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2018
1	TankyrasesIBA 12/2018
1	Interleukin-18 (Interleukin 18)IBA 12/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2017
1	sesaminIBA 01/2017
1	Hormones (Hormone)IBA 12/2014
1	ferric oxide (iron oxide)IBA 01/2014
1	PolyethyleneimineIBA 01/2014
1	erucylphosphocholineIBA 01/2014
1	RutheniumIBA 05/2012
1	ZincIBA 05/2012
1	PorphyrinsIBA 05/2012
1	CopperIBA 05/2012
1	NickelIBA 05/2012
1	TungstenIBA 05/2012

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2014
1	Time-to-Treatment 01/2023
1	Thrombectomy 01/2023
1	Electrodes (Electrode) 12/2022
1	Deep Brain Stimulation 12/2022
1	Personal Protective Equipment 10/2021
1	Cardiac Rehabilitation 10/2021
1	Secondary Prevention 10/2021
1	Precision Medicine 01/2020
1	Synchrotrons 12/2019